Lataa...
Duodenal mucosal risk markers in patients with familial adenomatous polyposis: effects of celecoxib/ursodeoxycholic acid co-treatment and comparison with patient controls
BACKGROUND: Familial adenomatous polyposis (FAP) is a disease characterized by the development of hundreds to thousands of adenomatous polyps in the colorectum early in life. Virtually all patients with FAP will develop colorectal cancer before the age of 40 to 50 years, unless prophylactic colectom...
Tallennettuna:
| Julkaisussa: | Orphanet J Rare Dis |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BioMed Central
2013
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4225600/ https://ncbi.nlm.nih.gov/pubmed/24245549 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1750-1172-8-181 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|